67. Polycystic kidney disease Clinical trials / Disease details

Clinical trials : 216 / Drugs : 219 - (DrugBank : 50) / Drug target genes : 39 - Drug target pathways : 151

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00890279 (ClinicalTrials.gov)	July 2009	28/4/2009	Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD)	Phase II Study for the Second-Line Treatment of Hypertension in Patients With Autosomal Dominant Polycystic Kidney Disease; ACEI vs. CCB	Kidney, Polycystic, Autosomal Dominant	Drug: Cilnidipine;Drug: Imidapril	Ministry of Health, Labour and Welfare, Japan	NULL	Recruiting	20 Years	60 Years	Both	160	Phase 2	Japan
2	NCT00541853 (ClinicalTrials.gov)	December 2007	9/10/2007	CCB Safety Study in Treatment of Hypertension of ADPKD	Comparison Between ARB and ARB Plus CCB on Incidence of Renal and Cardiovascular Events in Hypertensive ADPKD Patients	Kidney, Polycystic, Autosomal Dominant	Drug: Candesartan;Drug: Candesartan and Cilnidipine;Drug: Candesartan plus non-CCB agents	Kyorin University	Ministry of Health, Labour and Welfare, Japan	Not yet recruiting	20 Years	60 Years	Both	150	Phase 4	Japan